IP Verse

Hgf competitive analysis

Explore patent oppositions filed by Hgf against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Apr 9, 2026

Patent Number	Title	Applicant	Opposition Date
EP3784294	Compositions For Chelating Metals At Low Temperatures	UNIVERSITY OF IOWA RESEARCH FOUNDATION	Mar 4, 2026
EP4289948	Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription	CHARPENTIER	Nov 25, 2025
EP3693473	Methods And Materials For Assessing Allelic Imbalance	MYRIAD GENETICS	Nov 18, 2025
EP3752134	Methods And Compositions For Treating Vitiligo	CENTRE HOSPITALIER UNIVERSITAIRE DE NICE	Sep 3, 2025
EP3303401	Treatment Of Cancer By Manipulation Of Commensal Microflora	THE UNIVERSITY OF CHICAGO	Jul 16, 2025
EP3770258	Modulation Of Ube3A-Ats Expression	BAYLOR COLLEGE OF MEDICINE	Apr 16, 2025
EP4041186	An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis	LEO PHARMA	Feb 24, 2025
EP2662094	Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors	ONYX THERAPEUTICS	Jan 17, 2025
EP3184632	Hyperactive Piggybac Transposases	POSEIDA THERAPEUTICS	Jan 2, 2025
EP3628319	Methods Of Treating Hepatic Encephalopathy Using Rifaximin	SALIX PHARMACEUTICALS	Nov 4, 2024

Discover the latest PTAB cases involving Hgf, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hgf with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Apr 9, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
HGF	77	-	-	-
CHARPENTIER	-	21	-	-
NOVARTIS	6	441	-	21
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	-	35	-	19